San Diego-based ResMed has opened a €30m technology R&D facility in Sandyford, Co Dublin and announced plans to add 70 jobs over the next four years.
The new workers will support innovation, technology development and product development, with high-paying roles in mobile, AWS, and full-stack software development, and algorithm/machine learning engineering.
ResMed is a leading provider of connected devices, masks and accessories for the treatment of sleep apnea, a chronic sleeping disease affecting 936m people, including 600,000 in Ireland, and its Ireland-based ResMed Sensor Technologies division has developed many of its products.
"This investment will support the continued growth of ResMed’s product portfolio to meet the needs of patients across Ireland, Europe, and the world. It will also create new capabilities and skills within our expanding team in Ireland and support our global innovation strategy," said Mick Farrell, CEO of ResMed.
Speaking at the opening, Tánaiste and Minister for Enterprise, Trade and Employment Leo Varadkar said: “These 70 new jobs, which ResMed is creating over the next four years, alongside a commitment of €30m investment in research and development is really welcome.
In Association with
"Ireland has become recognised globally for the talent of our workforce, especially in the area of healthcare technology and medical devices. ResMed’s products make a real difference to so many people’s lives and it’s great Ireland is playing such an important role in that effort."
Mary Buckley, executive director of IDA Ireland, which supported the investment, said: “Continued investment in the area of Research & Development is central to IDA Ireland’s strategy ‘Driving Recovery and Sustainable Growth 2021-2024’.
"This investment by ResMed is very welcome and demonstrates the company’s commitment to Ireland. It is also an endorsement of the talented team in Dublin who have won this R&D mandate due to their track record in delivering innovative solutions.”
ResMed brought in revenues of $3.2bn during its 2020-21 financial year, making net income of €475m. As of last June, the company had close to 8,000 workers, including 1,380 in Europe.
Photo: Mick Farrell, Mary Buckley and Leo Varadkar with staff at ResMed's R&D facility in Sandyford.
